Suppr超能文献

甲状腺自身抗体阳性的抗N-甲基-D-天冬氨酸受体脑炎

Thyroid Autoantibody Positive Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

作者信息

Jung Yoori, Park Soonwon, Son Hwan-Jun, Jung Dae Soo, Sa Eun Hi, Lee Sun-Tae, Kim Eun-Soo, Jung Na-Yeon, Kim Eun-Joo

机构信息

Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, Korea.

Department of Neurology, Pusan New Hongje Hospital, Busan, Korea.

出版信息

Dement Neurocogn Disord. 2016 Mar;15(1):24-27. doi: 10.12779/dnd.2016.15.1.24. Epub 2016 Mar 31.

Abstract

BACKGROUND

Hashimoto's encephalopathy (HE) and anti N-methyl-D-aspartate receptor (NMDAR) encephalitis have clinical overlaps.

CASE REPORT

A 70-year-old woman presented with acutely developed confusion, disorientations and psychosis. HE was suspected based on goiter, markedly elevated anti-thyroglobulin and anti-thyroid peroxidase antibody. She was placed on high dose steroid and intravenous immunoglobulins administration, which did not ameliorate her symptoms. After the antibodies to the NMDAR were identified, weekly 500 mg of rituximab with 4 cycles were started. The current followed up indicated a complete recovery.

CONCLUSIONS

The possible associations between NMDAR antibody and autoimmune thyroid antibodies in anti-NMDAR encephalitis with positive thyroid autoantibodies remain unclear. However, a trend toward a higher incidence of NMDAR antibody in patients with autoimmune thyroid antibodies than without has been observed. Cases of encephalitis with only NMDAR antibody (pure anti-NMDAR encephalitis) also occur. Therefore, it is important for clinicians to know the clinical and pathogenic differences between anti-NMDAR encephalitis with positive thyroid autoantibody and pure anti-NMDAR encephalitis for relevant treatment, predicting prognosis, and future follow-up.

摘要

背景

桥本脑病(HE)与抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎存在临床重叠。

病例报告

一名70岁女性出现急性起病的意识模糊、定向障碍和精神病症状。基于甲状腺肿、抗甲状腺球蛋白和抗甲状腺过氧化物酶抗体显著升高怀疑为HE。给予她高剂量类固醇和静脉注射免疫球蛋白治疗,但症状未改善。在检测到NMDAR抗体后,开始每周给予500mg利妥昔单抗,共4个周期。目前的随访显示完全康复。

结论

甲状腺自身抗体阳性的抗NMDAR脑炎中,NMDAR抗体与自身免疫性甲状腺抗体之间的可能关联仍不清楚。然而,观察到有自身免疫性甲状腺抗体的患者中NMDAR抗体的发生率高于无该抗体的患者。也会出现仅存在NMDAR抗体的脑炎病例(纯抗NMDAR脑炎)。因此,对于临床医生而言,了解甲状腺自身抗体阳性的抗NMDAR脑炎与纯抗NMDAR脑炎之间的临床和致病差异对于相关治疗、预测预后及未来随访很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c7/6427959/4ed234da9dd0/dnd-15-24-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验